This mechanistic research showed that ROCK2 was the direct target of miR-101 and that ROCK2 overexpression reversed miR-101-mediatedEMT and cisplatin resistance in NSCLC cells. The gene discussed is ROCK2; the disease is non-small cell lung carcinoma.